p53 antiproliferative function is enhanced by aspartate substitution at threonine 18 and serine 20

被引:21
作者
Jabbur, JR
Zhang, W
机构
[1] Univ Texas, MD Anderson Canc Ctr, Canc Genom Lab, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Grad Program Canc Biol, Houston, TX 77030 USA
关键词
mutagenesis; Mdm-2; p21(Waf1/Cip1); Fas/APO-1; transactivation; protein conformation; growth regulation;
D O I
10.4161/cbt.81
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous studies have demonstrated the irradiation-induced phosphorylation of p53 at Thr18 and Ser20, residues integral within an a-helical segment of the transactivation domain. Importantly, phosphorylation at either site has been correlated with decreased binding to the inhibitory partner Mdm-2 and enhanced transactivation of p53 target genes. In this study, we investigated the impact of Asp substitution at Thr18 and Ser20 (p53T18D/S20D) on the functional regulation of p53. Asp substitution is commonly accepted as a means of mimicking phosphorylation due to the introduction of negative charge within the functional group. p53T18D/S20D was refractory to in vitro digestion by calpain, a protease recognizing a-helical structure within the transactivation domain. In addition, transfected p53T18D/S20D poorly bound GST-Mdm-2 in vitro, enhanced the endogenous expression of the p53 transactivation targets p21(Waf1/Cip1) and fas/APO-1, and significantly curtailed cell proliferation relative to wild-type p53 transfected cells. Thus, Asp substitution at Thr18 and Ser20 within the a-helical segment of the transactivation domain reduced Mdm-2 interaction, upregulating transactivation of cell-cycle and apoptotic regulatory targets, curtailing cellular proliferation.
引用
收藏
页码:277 / 283
页数:7
相关论文
共 64 条
[11]   Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2 [J].
Dumaz, N ;
Meek, DW .
EMBO JOURNAL, 1999, 18 (24) :7002-7010
[12]   Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15 [J].
Dumaz, N ;
Milne, DM ;
Meek, DW .
FEBS LETTERS, 1999, 463 (03) :312-316
[13]   Regulation of p53 downstream genes [J].
El-Deiry, WS .
SEMINARS IN CANCER BIOLOGY, 1998, 8 (05) :345-357
[14]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[15]   Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53 [J].
Fang, SY ;
Jensen, JP ;
Ludwig, RL ;
Vousden, KH ;
Weissman, AM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :8945-8951
[16]  
FISCELLA M, 1993, ONCOGENE, V8, P1519
[17]   The complexity of p53 modulation: emerging patterns from divergent signals [J].
Giaccia, AJ ;
Kastan, MB .
GENES & DEVELOPMENT, 1998, 12 (19) :2973-2983
[18]   Identification of a CK2 phosphorylation site in mdm2 [J].
Götz, C ;
Kartarius, S ;
Scholtes, P ;
Nastainczyk, W ;
Montenarh, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 266 (02) :493-501
[19]   Synergistic activation of transcription by CBP and p53 [J].
Gu, W ;
Shi, XL ;
Roeder, RG .
NATURE, 1997, 387 (6635) :819-823
[20]   ei24, a p53 response gene involved in growth suppressio and apoptosis [J].
Gu, ZM ;
Flemington, C ;
Chittenden, T ;
Zambetti, GP .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (01) :233-241